Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma | EUROPEAN JOURNAL OF CANCER |